Christopher Ianelli - 03 Jan 2023 Form 4 Insider Report for iSpecimen Inc. (ISPC)

Reporting relationship: Director
Issuer ticker: ISPC
Reported as of: 03 Jan 2023
Net transaction value: +$14,945
SEC form: 4
Accepted by SEC: 19 Jan 2023, 17:32:41 UTC
Prior SEC filing: 17 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Christopher Ianelli

Key filing fact

Christopher Ianelli filed Form 4 for iSpecimen Inc. (ISPC) on 19 Jan 2023.

Key facts

This page summarizes Christopher Ianelli's Form 4 filing for iSpecimen Inc. (ISPC).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 Jan 2023, 17:32.

Change

Previous filing in this sequence was filed on 17 May 2023.
Current net transaction value: +$14,945.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISPC transaction

Common Stock

Options Exercise

Transaction value: $845
Shares: +845
Change %: +0.2%
Price: $1.00
Shares after: 425,359
Date: 06 Jan 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISPC transaction Derivative

Option

Award

Transaction value: $14,100
Shares: +10,000
Change %: +1183%
Price: $1.41
Shares after: 10,845
Date: 03 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $1.41
Footnotes: F2

ISPC transaction Derivative

Option

Options Exercise

Transaction value: $0
Shares: -845
Change %: -7.8%
Price: $0.000000
Shares after: 10,000
Date: 06 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 845
Exercise price: $1.00
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.

Footnote F2

Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest with respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

Footnote F3

Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023.

Footnote F4

Represents remaining granted stock options across all grants.